Niki BioSolutions NIKI
NASDAQ NIKI
$4.60 -0.26 (-5.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Niki BioSolutions (NIKI) Gross Profit (2025)

Updated

Niki BioSolutions (NIKI) posted Gross Profit of $226,248 for FY2025.

Analysis

Niki BioSolutions (NIKI) Gross Profit (2025) Analysis & Trends

  • Annual Gross Profit shows a three-year compound annual growth rate of 41.4% (FY2022 to FY2025).
  • Business Quant data shows NIKI's Gross Profit at $10,566 in FY2023 (-86.8%) and $80,065 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Niki BioSolutions 2.65 Mn 2.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 18,426.00
API Access

Niki BioSolutions Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=NIKI&period=max&api_key=YOUR_API_KEY